India Approves Takeda's 2-Dose QDENGA for Ages 4-60 as Dengue Cases Rose 11-Fold
India's DCGI Approves Takeda's QDENGA, First Dengue Vaccine for Ages 4-60India Approves First Dengue Vaccine, QDENGA (TAK-003), from Takeda for Ages 4-60India approves first dengue vaccine, Japanese firm Qdenga formula will protect against all four virus subtypes - India TodayThe Voice of Chandigarh1d ago Takeda's QDENGA (TAK-003) becomes the first dengue vaccine to be approved in India, marking a new era in dengue prevention - The Voice of ChandigarhIndia Approves First Dengue Vaccine, DCGI Clears Takeda's QDENGA for Ages 4–60 | #therightstandIndia's DCGI Approves Takeda's TAK-003 Dengue Vaccine for Ages 4-60India has approved its first dengue vaccine, QDENGA (TAK-003), developed by Takeda Biopharmaceuticals India, for individuals aged 4 to 60 years. #Indianews #DenguevaccineIn a major public health milestone, India has approved its first dengue vaccine, Takeda's QDENGA. The vaccine has been cleared for people aged 4 to 60 years and offers protection against allTakeda's QDENGA Becomes India's First Approved Dengue Vaccine | BioPatrika